CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-20 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −801 | $420.79 | $337K | 19,710 |
| 2024-02-20 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes 10b5-1 | −3,373 | $420.58 | $1.4M | 67,846 |
| 2024-02-20 | Arbuckle Stuart A EVP, COO | Sale 10b5-1 | −4,804 | $420.79 | $2.0M | 63,042 |
| 2024-02-20 | ALTSHULER DAVID EVP, Global Research and CSO | Shares withheld for taxes 10b5-1 | −2,812 | $420.58 | $1.2M | 41,026 |
| 2024-02-20 | ALTSHULER DAVID EVP, Global Research and CSO | Sale 10b5-1 | −4,002 | $420.79 | $1.7M | 37,024 |
| 2024-02-16 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −3,750 | $424.01 | $1.6M | 59,704 |
| 2024-02-16 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −4,499 | $424.01 | $1.9M | 63,680 |
| 2024-02-16 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes 10b5-1 | −3,498 | $424.01 | $1.5M | 70,866 |
| 2024-02-16 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −9,359 | $424.01 | $4.0M | 152,912 |
| 2024-02-16 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −3,750 | $424.01 | $1.6M | 43,060 |
| 2024-02-16 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −1,501 | $424.01 | $636K | 21,636 |
| 2024-02-16 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes 10b5-1 | −4,499 | $424.01 | $1.9M | 71,219 |
| 2024-02-16 | ALTSHULER DAVID EVP, Global Research and CSO | Shares withheld for taxes 10b5-1 | −3,750 | $424.01 | $1.6M | 43,838 |
| 2024-02-15 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −4,655 | $419.16 | $2.0M | 17,896 |
| 2024-02-14 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −4,356 | $419.04 | $1.8M | 22,551 |
| 2024-02-13 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −737 | $419.13 | $309K | 26,907 |
| 2024-02-12 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −2,009 | $419.22 | $842K | 28,291 |
| 2024-02-12 | LEIDEN JEFFREY M Executive Chairman | Sale 10b5-1 | −647 | $420.39 | $272K | 27,644 |
| 2024-02-12 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −314 | $420.24 | $132K | 68,179 |
| 2024-02-12 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −3,222 | $420.24 | $1.4M | 74,364 |
Page 23 of 27 · 524 trades